-
-
JOINN Biologics licensed by FDA
Jan 22, 2021
JOINN Biologics Technology Co in the Zhongguancun Demonstration Zone recently passed review by the US Food and Drug Administration and was licensed for production, another milestone for the company after passing the EU Qualified Person (QP) audit.
-
EdiGene approved for clinical trial of China's first gene-editing therapy
Jan 22, 2021
The State Food and Drug Administration recently approved the clinical trial application of Zhongguancun Biopharmaceutical Enterprise EdiGene's gene-editing therapy product ET-01 for transfusion-dependent β-thalassemia.
-
ZGC Shunyi Park forms complete industry chain for 3rd-gen semiconductors
Jan 21, 2021
The third-generation semiconductor industry is one of the advanced sectors in Beijing.
-
Shijingshan's '2+N' policy system spurs innovation
Jan 19, 2021
Shijingshan district issued the "2+N" policy system in June 2020, which boosted enterprises' confidence in the Zhongguancun Shijingshan Science Park during the pandemic and received wide attention.
-
Zhongguancun Medical Device Park recognized for IP protection work
Jan 15, 2021
Zhongguancun Medical Device Park is located in the middle of the third phase of the Daxing Biomedical Industry Base, with a total construction area of about 400,000 square meters.
-
Research by ZGC Life Science Park published in Nature
Jan 14, 2021
Renowned academic journal Nature will soon be publishing scientific research from Beijing's Zhongguancun Life Science Park.
-
Zhongguancun welcomes overseas returnees to start businesses
Jan 14, 2021
Zhongguancun Administrative Committee recently issued new policies to support overseas returnees to start businesses in the Zhongguancun Science Park.
Links
Tel: 010-88828800
Email: xuanchuan@zgcgw.beijing.gov.cn
Fax: 010-88828882
Copyright © Administrative Committee of Zhongguancun Science Park.
All Rights Reserved. Presented by China Daily.